In this study, we reported a case of ALK-positive NSCLC with multiple renal cysts and renal dysfunction during crizotinib therapy and described the functional and pathological changes observed after long-term administration of crizotinib in an experimental mouse model. The gene discussed is ALK; the disease is cystic kidney disease.